Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon May 02, 2022 10:26am
87 Views
Post# 34647392

RE:RE:Valuation

RE:RE:Valuation
EbbFlow88 wrote: Thanks Gudisgood. I've done that same thought process many times and have come to the exact same conclusion.

I also like to think that if you subtract the cash and investments from the market cap you get around 300M which would pretty much double your yield to 14-15%. 

Assuming they can invest cash at similar returns, that's what return we can expect over time. Add in efficiencies and it increases the upside.


You guys are right on the money - it's just one of those stories where the market doesn't see it until the market sees it.  That's fine with me because while the market sleeps, GUD will grow (next few years) and the confusing financial side of the business gets smaller while operations ramp.

That's when the market says - wow - why don't we own this one ?

Deja vu !
<< Previous
Bullboard Posts
Next >>